| Literature DB >> 32685024 |
Vivek K Bajpai1, Imran Khan2,3, Shruti Shukla4, Sung-Min Kang5, Faisal Aziz3, Kumud Malika Tripathi6, Deepika Saini7, Hye-Jin Cho8, Nam Su Heo9, Sumit K Sonkar7, Lei Chen10, Yun Suk Huh2, Young-Kyu Han1.
Abstract
Rationale: The present study reEntities:
Keywords: B16F10 melanoma cells; N-P-doping; apoptosis; autophagy; bioimaging; cell cycle arrest
Mesh:
Substances:
Year: 2020 PMID: 32685024 PMCID: PMC7359102 DOI: 10.7150/thno.42291
Source DB: PubMed Journal: Theranostics ISSN: 1838-7640 Impact factor: 11.556
Scheme 1Schematic representation showing the synthesis of nitrogen-phosphorous-doped carbon dots (NPCDs).
Figure 1Optical and morphological characterization of nitrogen-phosphorous-doped carbon dots (NPCDs). (A) UV-visible and fluorescence emission spectra, (B) a low-resolution transmission electron microscopy (TEM) image with size histogram in inset image, (C and D) high-resolution TEM images.
Figure 2Structural characterization of nitrogen-phosphorous-doped carbon dots (NPCDs). (A) Full survey XPS scan with elemental composition; the corresponding deconvoluted spectra of (B) C1s, (C) O1s, (D) N1s, and (E) P2p short scans; and (F) FTIR spectra of NPCDs.
Figure 3Cytotoxic potential of nitrogen-/phosphorous-doped carbon dots (NPCDs) against B16F10 melanoma cells. (A and B) MTT and LDH assay, respectively of the NPCDs (0-30 μL/mL)-treated cells after 24 h of incubation. (C) Apoptosis assay after treatment with NPCDs measured at A405 (D) Morphological changes in B16F10 cells after treatment with NPCDs (0-30 μL/mL). Images were captured at 20× magnification [scale bar =0.1 mm]. (E) Clonogenic assay where B16F10 cells were cultured in the presence and absence of NPCDs over 7 days, and then subjected to crystal violet staining. Each value in the bar graph represents the mean ±SD of three independent experiments. Values with different superscripts differ significantly from each other (P < 0.05).
Figure 4Evaluation of the morphological and internal cellular damage to B16F10 melanoma cancer cells after treatment with nitrogen-/phosphorous-doped carbon dots (NPCDs) via scanning electron microscopy (SEM) and bio- transmission electron microscopy (bio-TEM) analysis. (A) SEM images of the (i) control and (ii) 5 μL/mL, (iii) 15 μL/mL and (iv) 30 μL/mL NPCD-treated B16F10 cells; and (B) Bio-TEM images of the (i) control and (ii) 30 μL/mL NPCD-treated B16F10 cells. L, lysosome; LE, late lysosome; V, vacuole; MI, mitochondrion; and R: ribosome (Scale: 1 μm).
Figure 5Nitrogen-/phosphorous-doped carbon dots (NPCDs; 0-30 μL/mL)-induced apoptotic morphology in B16F10 melanoma cancer cells. Apoptotic morphology was evaluated by A) live-dead cells and B) Hoechst-PI staining. (C) Western blot analysis of various apoptotic markers (caspase-3, Bcl2, and Bax) and Image J analysis. (D) Immunocytochemistry of prominent apoptosis marker cleaved caspase-3 after treatment with NPCDs evaluated via confocal microscopy. The data are represented as the mean ± standard deviation (SD) of three independent experiments: ***P < 0.001, **P < 0.01, * P < 0.05 vs. the control. Fluorescence images were captured at 20× magnification (scale bar = 0.1 mm).
Figure 6Nitrogen-/phosphorous-doped carbon dots (NPCDs; 0-30 μL/mL)-induced cytosolic and mitochondrial ROS production in B16F10 melanoma cancer cells. (A) cytosolic ROS production determined by H2DCFDA counterstaining with DAPI and (B) Rhodamine 123 staining detected by fluorescence microscopy. Fluorescence intensities of (C) cytosolic and (D) mitochondrial ROS showing results corresponding to (i) the control and (ii) 5, (iii) 15, and (iv) and 30 μL/mL of NPCDs. ImageJ software was used to plot their respective intensities. Fluorescence images were captured at 20× magnification (scale bar = 0.1 mm). The data are represented as the mean ± standard deviation (SD) of three independent experiments: ***P < 0.001, **P < 0.01, * P < 0.05 vs. the control.
Figure 7Effect of nitrogen-/phosphorous-doped carbon dots on cell cycle arrest markers. (A) Western blot analysis of various cell cycle arrest markers (CDK-2, -4, and -6 and p21) and (B) ImageJ analysis of B16F10 melanoma cancer cells after treatment with nitrogen-/phosphorous-doped carbon dots (NPCDs; 0-30 μL/mL). (C) Immunocytochemistry of cell cycle arrest marker CDK-4 after treatment with NPCDs evaluated via confocal microscopy. The data are represented as the mean ± standard deviation (SD) of three independent experiments: ***P < 0.001, **P < 0.01, * P < 0.05 vs. the control.
Figure 8Effect of nitrogen-/phosphorous-doped carbon dots on autophagy markers. (A) Western blot analysis of various autophagy markers (LC3, ATG-5, and p62) and (B) ImageJ analysis of B16F10 melanoma cancer cells after treatment with nitrogen-/phosphorous-doped carbon dots (NPCDs; 0-30 μL/mL). (C) Immunocytochemistry of prominent autophagy marker LC3 after treatment with NPCDs evaluated via confocal microscopy. (D) Autophagic vacuole formation after treatment with NPCDs detected via confocal microscopy. (E) ImageJ analysis of autophagic vacuole formation. (F and G) Validation of autophagic vacuole formation evaluated in the presence of 3-methyladenine ((3-MA) preincubated with 2.5 mM for 1 h and then incubated with NPCDs for 24h). The data are represented as the mean ± standard deviation (SD) of three independent experiments: ***P < 0.001, **P < 0.01, * P < 0.05 vs. the control; ###P < 0.001, ##P < 0.01, # P < 0.05 vs. the control.
Figure 9Application of nitrogen-/phosphorous-doped carbon dots (NPCDs) in B16F10 melanoma cell bioimaging. Treatment of the B16F10 melanoma cancer cells gave rise to dose-dependent green, red, and blue fluorescence after 30 min of incubation in the dark. Cells emitting blue, green, and red fluorescence at, ex: 450-500 nm, ex: 500-570 nm and ex: 610-750 nm.
Figure 10Anticancer mechanism of nitrogen-/phosphorous-doped carbon dots (NPCDs) against B16F10 melanoma cells.